Globus Medical, Inc. (NYSE:GMED – Get Rating) has been assigned an average recommendation of “Buy” from the fourteen research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among […]